Clinical Characteristics of Asymptomatic Patients with COVID-19: A Nationwide Cohort Study in South Korea
Objectives: To delineate clinical characteristics of asymptomatic and symptomatic patients confirmed with COVID-19 in South Korea. Methods: Data were obtained from the Korean National Health Insurance Service database linked to the Korea Centers for Disease Control and Prevention data. Results: Among 10,237 patients (mean [SD] age, 45.0 [19.8] years; 60.1% female) who met the eligibility criteria for the study, 6,350 (62.0%) patients were asymptomatic, and 3,887(38.0%) patients were symptomatic. The mean and median age were similar between asymptomatic and symptomatic patients. Notably, we observed a U-shaped association between age group and the proportion of asymptomatic patients, with the nadir at 57.3% in the 40-49 age group. This U-shaped distribution was largely similar between men and women. The overall prevalence of asymptomatic individuals was higher, regardless of sex, residential area, income levels, and comorbid conditions. Conclusions: In this national cohort of over 10,000 patients with COVID-19, more than 60% of all cases in South Korea reported no symptoms at the time of diagnosis. Expanding criteria for contact tracing and testing to capture potential transmission before symptom onset should be urgently considered to inform control strategies for COVID-19..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:99 |
|---|---|
| Enthalten in: |
International Journal of Infectious Diseases - 99(2020), Seite 266-268 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chan-Young Jung [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Asymptomatic |
|---|
| doi: |
10.1016/j.ijid.2020.08.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ027666271 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ027666271 | ||
| 003 | DE-627 | ||
| 005 | 20230307115835.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2020.08.001 |2 doi | |
| 035 | |a (DE-627)DOAJ027666271 | ||
| 035 | |a (DE-599)DOAJ21a5f891486049c5aabd93e565b8f114 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Chan-Young Jung |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Characteristics of Asymptomatic Patients with COVID-19: A Nationwide Cohort Study in South Korea |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Objectives: To delineate clinical characteristics of asymptomatic and symptomatic patients confirmed with COVID-19 in South Korea. Methods: Data were obtained from the Korean National Health Insurance Service database linked to the Korea Centers for Disease Control and Prevention data. Results: Among 10,237 patients (mean [SD] age, 45.0 [19.8] years; 60.1% female) who met the eligibility criteria for the study, 6,350 (62.0%) patients were asymptomatic, and 3,887(38.0%) patients were symptomatic. The mean and median age were similar between asymptomatic and symptomatic patients. Notably, we observed a U-shaped association between age group and the proportion of asymptomatic patients, with the nadir at 57.3% in the 40-49 age group. This U-shaped distribution was largely similar between men and women. The overall prevalence of asymptomatic individuals was higher, regardless of sex, residential area, income levels, and comorbid conditions. Conclusions: In this national cohort of over 10,000 patients with COVID-19, more than 60% of all cases in South Korea reported no symptoms at the time of diagnosis. Expanding criteria for contact tracing and testing to capture potential transmission before symptom onset should be urgently considered to inform control strategies for COVID-19. | ||
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-COV-2 | |
| 650 | 4 | |a Asymptomatic | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a Haeyong Park |e verfasserin |4 aut | |
| 700 | 0 | |a Dong Wook Kim |e verfasserin |4 aut | |
| 700 | 0 | |a Yoon Jung Choi |e verfasserin |4 aut | |
| 700 | 0 | |a Seong Woo Kim |e verfasserin |4 aut | |
| 700 | 0 | |a Tae Ik Chang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t International Journal of Infectious Diseases |d Elsevier, 2015 |g 99(2020), Seite 266-268 |w (DE-627)DOAJ000043923 |x 18783511 |7 nnns |
| 773 | 1 | 8 | |g volume:99 |g year:2020 |g pages:266-268 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijid.2020.08.001 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/21a5f891486049c5aabd93e565b8f114 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1201971220306342 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1201-9712 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 99 |j 2020 |h 266-268 | ||